Adrenoleukodystrophy

Overview

What is adrenoleukodystrophy?

Adrenoleukodystrophy is a genetic condition that primarily affects males and leads to problems with the adrenal glands and the nervous system. The adrenal glands function to produce hormones and are located above the kidneys. There are multiple forms of X-linked adrenoleukodystrophy that can be divided based on the symptoms that are present in any one particular patient. Childhood cerebral forms have an onset of ages 4-8 and symptoms include attention problems, poor school performance, difficulty in understanding speech, reading comprehension problems, clumsiness, and problems with eyesight. Children with this form may also have seizures and problems progress over time. The adrenomyeloneuropathy (AMN) form has symptoms often beginning in 20s-40s and symptoms include leg weakness, difficulties with digestion and sexual dysfunction that gets worse with time. Individuals with the Addison-disease-only type typically start showing symptoms in childhood that may include vomiting, weakness and changes in skin coloring. These problems can be helped with hormone replacement therapy.

References
Show More Content Like This

More Overview Content

Are there other names for adrenoleukodystrophy?

How common is X-linked adrenoleukodystrophy?

What is the usual abbreviation for adrenoleukodystrophy?

Are any specific ethnic groups at an increased risk for X-linked adrenoleukodystrophy?

Are there other names for adrenoleukodystrophy?

Adrenoleukodystrophy is also called X-linked adrenoleukodystrophy, referring to how it's inherited or passed through families. Adrenoleukodystrophy and X-linked adrenoleukodystrophy are the most up-to-date names for the condition. It has also been called Addison disease and cerebral sclerosis, Siemerling-Creutzfeldt Diease, Bronze Schilder Disease, melanodermic leukodystrophy, Schilder-Addison Complex, and Schilder disease.

References
How common is X-linked adrenoleukodystrophy?

The prevalence of X-linked adrenoleukodystrophy is estimated to be between 1:20,000 to 1:50,000. In the United States, at least 1 in 21,000 males are estimated to be affected.

References
What is the usual abbreviation for adrenoleukodystrophy?

Adrenoleukodystrophy can be abbrievated ALD or X-ALD, for X-linked adrenoleukodystrophy.

References
Are any specific ethnic groups at an increased risk for X-linked adrenoleukodystrophy?

The number of people with X-linked adrenoleukodystrophy does not seem to be different among people of varying ethnic groups.

References

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more about our use of cookies and similar technology

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me